(Total Views: 441)
Posted On: 11/28/2019 11:54:11 AM
Post# of 149265
NASH and fatty liver is a big problem , touches about 100 mil people in USA..
With Leronlimab almost no fat deposits in the liver , and also they saw reduced fibrosis in the liver.
Two major components for NASH , Fat deposit and fibrosis , much improved ( almost no fat deposit )..Very positive studies .
With Leronlimab almost no fat deposits in the liver , and also they saw reduced fibrosis in the liver.
Two major components for NASH , Fat deposit and fibrosis , much improved ( almost no fat deposit )..Very positive studies .
(1)
(0)Scroll down for more posts ▼
